- Home
- HTCR vs NRXS Comparison
HTCR vs NRXS Comparison
Compare HTCR & NRXS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HTCR
- NRXS
- Stock Information
- Founded
- HTCR 2009
- NRXS 2011
- Country
- HTCR Japan
- NRXS United States
- Employees
- HTCR N/A
- NRXS N/A
- Industry
- HTCR EDP Services
- NRXS
- Sector
- HTCR Technology
- NRXS
- Exchange
- HTCR Nasdaq
- NRXS Nasdaq
- Market Cap
- HTCR 11.9M
- NRXS 13.0M
- IPO Year
- HTCR 2022
- NRXS 2023
- Fundamental
- Price
- HTCR $0.46
- NRXS $2.43
- Analyst Decision
- HTCR
- NRXS Strong Buy
- Analyst Count
- HTCR 0
- NRXS 1
- Target Price
- HTCR N/A
- NRXS $7.00
- AVG Volume (30 Days)
- HTCR 127.9K
- NRXS 102.9K
- Earning Date
- HTCR 08-13-2025
- NRXS 08-08-2025
- Dividend Yield
- HTCR 4.35%
- NRXS N/A
- EPS Growth
- HTCR N/A
- NRXS N/A
- EPS
- HTCR N/A
- NRXS N/A
- Revenue
- HTCR $28,947,523.00
- NRXS $2,934,945.00
- Revenue This Year
- HTCR N/A
- NRXS $138,883.78
- Revenue Next Year
- HTCR $8.59
- NRXS $118.59
- P/E Ratio
- HTCR N/A
- NRXS N/A
- Revenue Growth
- HTCR 59.42
- NRXS 27.52
- 52 Week Low
- HTCR $0.39
- NRXS $1.33
- 52 Week High
- HTCR $3.38
- NRXS $6.20
- Technical
- Relative Strength Index (RSI)
- HTCR 42.19
- NRXS 47.39
- Support Level
- HTCR $0.42
- NRXS $2.23
- Resistance Level
- HTCR $0.48
- NRXS $2.75
- Average True Range (ATR)
- HTCR 0.04
- NRXS 0.17
- MACD
- HTCR -0.00
- NRXS -0.01
- Stochastic Oscillator
- HTCR 46.54
- NRXS 38.46
About HTCR Heartcore Enterprises Inc.
HeartCore Enterprises Inc is a software development company. The company provides software through two business units. The first business unit includes a customer experience management business. The customer experience management platform includes marketing, sales, service, and content management systems, as well as other tools and integrations that enable companies to attract and engage customers throughout the customer experience. It also provides education, services and support to help customers be successful with the CXM Platform. The second business unit, DX division, is a digital transformation business that provides customers with robotics process automation, process mining, and task mining to accelerate the digital transformation of enterprises.
About NRXS Neuraxis Inc.
Neuraxis Inc is a growth stage company is engaged in developing neuromodulation therapies to address chronic and debilitating conditions in children. The company is dedicated to advancing the science with its' proprietary Percutaneous Electrical Nerve Field Stimulation (PENFS) technology. The company focuses on targeted therapies for the pediatric and adolescent population suffering from disorders of gut-brain interaction (DGBIs).